Abstract
Communicable diseases are amongst the most common diseases world-wide, a significant part of which is attributable to sexually transmitted diseases (Sciarra 1997). They are caused by a variety of microorganisms, including bacteria, viruses, parasites, yeast, chlamydia, ureaplasma and mycoplasma. They are most often transmitted by penile-vaginal, oral-genital, and genital-anal contact. The physiological presence of lactobacilli in the vagina protects, to some extent, against external damage of the epithelium by microorganisms. The presence of cyclic ovarian function ensures that glycogen within the superficial cells of the vaginal epithelium is available as a nutrient for the lactobacilli which produce lactic acid to adjust the vaginal pH to 3.8-4. This ensures some protection against various pathogens known to cause (ascending) urogenital infections. However, frequently this barrier is disrupted by microorganisms. Common bacterial communicable diseases include chancroid, caused by the gram-negative bacillus Hemophilus ducreyi, to be the most common cause of genital ulcer disease; gonorrhea caused by the gramnegative diplococcus Neisseria gonorrhea; and syphilis caused by the spirochete Treponema pallidum. Common viral diseases are Herpes genitalis caused by herpes simplex virus type II and genital warts due to human papillomavirus (HPV) infection. One of the most serious health concerns today is the acquired immune deficiency syndrome (AIDS) caused by type I and II of human immunodeficiency virus (HIV). This affects approximately 17 million women worldwide (JOHNSON et al. 1994).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaby P, Ariyoshi K, Buckner M, Jensen H, Berry N, Wilkins A, Richard D, Larsen 0, Dias F, Melbye M, Whittle H(1996) Age of wife as a major determinant of male to female transmission of HIV-2 infection: a community study from rural West Africa. AIDS 10:1585–1590
AI-Sahili FL, Curran JP, Wang J (1974) Neonatal Trichomonas vaginalis: report of three cases and review of the literature.Pediatrics 53:196–200
Arya LP, Mallinson H, Goddard AD (1981) Epidemiological and clinical correlates of chlamydial infection of the cervix.Br J Vener Dis 57:118–124
Avonts D, Sercu M, Heyerick P, Vandermeeren I, Meheus A, Piot P (1990)Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis 17:23–29
Barbone F, Austin H, Louv WC, Alexander WJ (1990) A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis.Am J Obstet Gyneco1163:510–514
Blum M, Gilerovitch M, Benaim J, Appelbaum T (1990) The correlation between chlamydia antigen, antibody, vaginal colonization and contraceptive method in young, unmarried women.Adv Contracept 6:41–45
Carael M, van de Perre PH, Lepage PH, Allen S, Nsengumuremyi F, van Goethem C, Ntahorutaba M, Nzaramba D, Clumeck N (1988) Human immunodeficiency virus transmission among heterosexual couples in Central Africa.AIDS 2:201–205
Carlin EM, Boag FC (1995) Women, contraception and STDs including HIV.Int J STD AIDS 6:373–386
Cates W Jr, Stone KM(1992)Family planning, sexually transmitted diseases and contraceptive choice: a literature update-Part II. Fam Plann Perspect 24:122–128
Cottingham J, Hunter D (1992) Chlamydia trachomatis and oral contraceptive use: a quantitative review. Genitourin Med 68:209–216
Daly CC, Maggwa N, Mati JK, Solomon M, Mbugua S, Tukei PM, Hunter DJ (1994) Risk factors for gonorrhoea, syphilis, and trichomonas infections among women attending family planning clinics in Nairobi,Kenya. Genitourin Med 70:155–161
Deschamps M-M, Pape JW, Desvarieux M, Williams-Russo P, Madhavan S, Ho JL, Johnson WD J r (1993) A prospective study of HIV-seropositive asymptomatic women of childbearing age in a developing country.J Acquired Immune Defic Syndr 6:446–451
De Vincenzi I for The European Study Group on Heterosexual Transmission of HIV(1994)A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. New Engl 1 Med 331:341–346
European Study Group on Heterosexual Transmission of HIV (1992)Comparison of female to male and male to female transmission in 563 stable couples. Br Med 1 304:809–813
Grimes DA, Cates WIR (1990) Family planning and sexually transmitted diseases. 2nd edn. In: Holmes KK, Mardh PA, Sparling Pf (eds)Sexually transmitted diseases. McGraw-Hill, New York, pp 1087–1099
Hanna NF, Taylor-Robinson D, Kalodiki-Karamanoli M, Harris IRW, McFayden IR (1985) The relation between vaginal pH and the microbiological status in vaginitis. Brit 1 Obstet Gynaecol 92:1267–1271
Harrison HR, Costin M, Meder JB, Bownds LM, Sim DA, Lewis M, Alexander ER (1985) Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis.Am J Obstet Gyneco1153:244–251
Hicks D (1995) Hormonal contraception and HIY. Br 1 Family Planning 20:103–104
Johnson AM, de Cock KM(1994) What’s happening to AIDS. Br Med 1 309:1523–1524
Kalo-Klein A, Witkin SS (1989) Candida albicans: cellular immune system interactions during different stages of the menstrual cycle.Am 1 Obstet GynecoI161:1132–1136
Kjaer SK, Engholm G, Teisen C, Haugaard BL, Lynge E, Christensen RB, Moller KA, lensen H, Poll P, Vestergaard BF, de Villiers EM, lensen OM (1990) Risk factors for cervical human papillomavirus and herpes simplex infections in Greenland and Denmark: a population-based study.Am 1 Epidemiol131:169–182
Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M, Heyward WL, Ryder RW, Piot P(1993)Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95–102
Lehtinen M, Dillner 1, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, Koskela P, Paavonen J, Peto R, Schiller JT, Hakama M(1996)Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. Brit Med1 312:537–539
Louv WC, Austin H, Perlman J, Alexander WI (1989) Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet GynecoI 160:396–402
Martinotti MG, Savoia D (1985) Effect of some steroid hormones on the growth of Trichomonas vaginalis. G Batteriol Virol Immunol 78:52–59
Munoz N, Bosch FX (1992) HPV and cervical neoplasia: review of case-control and cohort studies.IARC Sci Pub I 119:251–261
Nelson AL(1997) The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle. Am J Obstet Gynecol 176:1376–1380
Parazzini F, La Vecchia C, Negri E, Maggi R (1990) Oral contraceptive use and invasive cervical cancer.Int J Epidemiol 19:259–263
Pater A, Bayatpour M, Pater MA(1990) Oncogenic transformation by humane papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives.Am J Obstet GynecoI162:1099–1103
Plummer FA, Simonsen IN, Cameron DW, Ndinya-Achola J0, Kreiss lK, Gakinya MN, Waiyali P, Cheang M, Piot P, Ronald AR, Ngugi EN(1991)Co-factors in malefemale sexual transmission of human immunodeficiency virus type 1. J Infect Dis 163:233–239
Rank RG, Barron AL(1987)Specific effect of estradiol on the genital mucosa antibody response in chlamydial ocular and genital infections. Infect Immunol 55:2317–2319
Ross IDC(1996)Is oral contraceptive associated with genital warts?Genitourin Med 72:330–333
Roy S (1991) Nonbarrier contraception and vaginitis and vaginosis.Am J ObstetGynecol 165:S1240–S1244
Rubin GL, Ory HW, Layde PM (1982) Oral contraceptives and pelvic inflammatory disease.Am J Obstet GynecoI144:630–635
Sciarra JJ(1997)Sexually transmitted diseases: global importance. Int J Gynecol Obstet 58:107–119
Segal E, Soroka A, Schechter A (1984)Correlative relationship between adherence of Candida albicans to human vaginal epithelial cells in vitro and candidal vaginitis.J Med Vet MycoI 22:191–200
Shah PN, Smith JR, Wells C, Barton SE, Kitchen VS, Steer PJ(1994) Menstrual symptoms in women infected by the human immunodeficiency virus. Obstet Gynecol 83:397–400
Sharma R, Pickering J, McCormack WM (1997)Trichomoniasis in a postmenopausal woman cured after discontinuation of estrogen replacement therapy. Sex Transm Dis 24:543–545
Smith EM, Johnson SR, Figuerres EJ, Mendoza M, Fedderson D, Haugen TH, Turek LP(1997) The frequency of human papillomavirus detection in postmenopausal women on hormone replacement therapy. Gynecol OncoI65:441–446
Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A(1995) The impact of oral contraception on vulvovaginal candidiasis. Contraception 51:293–297
Sweet RL (1985)Importance of differential diagnosis in acute vaginitis.Am J Obstet GynecoI152:921–923
Taitel HF, Kafrissen ME (1995) A review of combined pill use and risk of HIV transmission. Br J Fam Plann 20:112–116
Toppozada M, Onsy FA, Fares E, Amir S, Shaala S(1979)The protective influence of progestogen only contraception against vaginal moniliasis. Contraception 20:99–102
Wallin J, Gnarpe H, Forsgren A(1974) Sexually transmitted diseases in women. Br J Vener Dis 50:217–221
Westrom L(1980) Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 138:880–892
Widy-Wirski R, Berkley S, Downing R, Okware S, Recine U, Mugerwa R, Lwegaba A, Sempala S (1988)Evaluation of the WHO clinical case definition of AIDS in Uganda. J Am Med Assoc 260:3286–3289
Wolner-Hanssen P, Eschenbach D, Paavonen J, Kiviat N, Stevens LE, Critchlow C, DeRouen T, Holmes KK(1990) Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. J Am Med Assoc 263:54–59
Wolner-Hanssen P, Svensson L, Mardh PA, Westrom L (1985) Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. Obstet Gynecol 66:233–238
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg New York
About this chapter
Cite this chapter
Dören, M. (1993). Estrogens and Sexually Transmitted Diseases. In: Estrogens and Antiestrogens II. Handbook of Experimental Pharmacology, vol 135 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60107-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-60107-1_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64261-6
Online ISBN: 978-3-642-60107-1
eBook Packages: Springer Book Archive